This report aims to provide a comprehensive presentation of the global market for Non-steroidal Anti-inflammatory Drugs (NSAID), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-steroidal Anti-inflammatory Drugs (NSAID). This report contains market size and forecasts of Non-steroidal Anti-inflammatory Drugs (NSAID) in global, including the following market information:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Non-steroidal Anti-inflammatory Drugs (NSAID) companies in 2022 (%)
The global Non-steroidal Anti-inflammatory Drugs (NSAID) market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Salicylates Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial and Merck Animal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Type, 2022 (%)
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, by Application, 2022 (%)
Human
Animals
Others
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) revenues share in global market, 2022 (%)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Non-steroidal Anti-inflammatory Drugs (NSAID) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-steroidal Anti-inflammatory Drugs (NSAID), market overview.
Chapter 2: Global Non-steroidal Anti-inflammatory Drugs (NSAID) market size in revenue and volume.
Chapter 3: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-steroidal Anti-inflammatory Drugs (NSAID) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Overall Market Size
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2022 VS 2030
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales: 2018-2030
3 Company Landscape
3.1 Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.2 Top Global Non-steroidal Anti-inflammatory Drugs (NSAID) Companies Ranked by Revenue
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies
3.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies
3.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market
3.8.1 List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Markets, 2022 & 2030
4.1.2 Salicylates
4.1.3 Propionic acid derivatives
4.1.4 Acetic acid derivatives
4.1.5 Enolic acid (Oxicam) derivatives
4.1.6 Anthranilic acid derivatives (Fenamates)
4.1.7 Selective COX-2 inhibitors (Coxibs)
4.1.8 Sulfonanilides
4.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
4.2.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
4.2.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2030
4.2.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
4.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
4.3.1 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
4.3.2 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2030
4.3.3 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
4.4 By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2022 & 2030
5.1.2 Human
5.1.3 Animals
5.1.4 Others
5.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
5.2.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
5.2.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2030
5.2.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
5.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
5.3.1 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
5.3.2 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2030
5.3.3 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
5.4 By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2022 & 2030
6.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue & Forecasts
6.2.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2023
6.2.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2024-2030
6.2.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
6.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales & Forecasts
6.3.1 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2023
6.3.2 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2024-2030
6.3.3 By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2030
6.4.2 By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2030
6.4.3 US Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.4.4 Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.4.5 Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2030
6.5.2 By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2030
6.5.3 Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.5.4 France Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.5.5 U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.5.6 Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.5.7 Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.5.8 Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.5.9 Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2030
6.6.2 By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2030
6.6.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.6.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.6.5 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.6.6 Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.6.7 India Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2030
6.7.2 By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2030
6.7.3 Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.7.4 Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, 2018-2030
6.8.3 Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.8.4 Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.8.5 Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
6.8.6 UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Ecotrin
7.2.1 Ecotrin Company Summary
7.2.2 Ecotrin Business Overview
7.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.2.5 Ecotrin Key News & Latest Developments
7.3 Generic
7.3.1 Generic Company Summary
7.3.2 Generic Business Overview
7.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.3.5 Generic Key News & Latest Developments
7.4 St. Joseph
7.4.1 St. Joseph Company Summary
7.4.2 St. Joseph Business Overview
7.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.4.5 St. Joseph Key News & Latest Developments
7.5 Elanco
7.5.1 Elanco Company Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.5.5 Elanco Key News & Latest Developments
7.6 Zoetis
7.6.1 Zoetis Company Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.6.5 Zoetis Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Merial
7.8.1 Merial Company Summary
7.8.2 Merial Business Overview
7.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.8.5 Merial Key News & Latest Developments
7.9 Merck Animal Health
7.9.1 Merck Animal Health Company Summary
7.9.2 Merck Animal Health Business Overview
7.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Major Product Offerings
7.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Revenue in Global (2018-2023)
7.9.5 Merck Animal Health Key News & Latest Developments
8 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, Analysis
8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity, 2018-2030
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-steroidal Anti-inflammatory Drugs (NSAID) Supply Chain Analysis
10.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Upstream Market
10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID) in Global Market
Table 2. Top Non-steroidal Anti-inflammatory Drugs (NSAID) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Companies, 2018-2023
Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Companies, (K Units), 2018-2023
Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
Table 9. List of Global Tier 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-steroidal Anti-inflammatory Drugs (NSAID) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2018-2023
Table 15. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2024-2030
Table 16. By Application ? Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2018-2023
Table 20. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2024-2030
Table 21. By Region ? Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2018-2023
Table 25. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), 2024-2030
Table 26. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 29. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2030
Table 30. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 33. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2030
Table 34. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 37. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2030
Table 38. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 41. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, (K Units), 2024-2030
Table 46. Bayer Company Summary
Table 47. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 48. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Ecotrin Company Summary
Table 51. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 52. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Ecotrin Key News & Latest Developments
Table 54. Generic Company Summary
Table 55. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 56. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Generic Key News & Latest Developments
Table 58. St. Joseph Company Summary
Table 59. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 60. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. St. Joseph Key News & Latest Developments
Table 62. Elanco Company Summary
Table 63. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 64. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Elanco Key News & Latest Developments
Table 66. Zoetis Company Summary
Table 67. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 68. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Zoetis Key News & Latest Developments
Table 70. Boehringer Ingelheim Company Summary
Table 71. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 72. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Boehringer Ingelheim Key News & Latest Developments
Table 74. Merial Company Summary
Table 75. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 76. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Merial Key News & Latest Developments
Table 78. Merck Animal Health Company Summary
Table 79. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offerings
Table 80. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Merck Animal Health Key News & Latest Developments
Table 82. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2018-2023 (K Units)
Table 85. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Region, 2024-2030 (K Units)
Table 86. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Opportunities & Trends in Global Market
Table 87. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers in Global Market
Table 88. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints in Global Market
Table 89. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials
Table 90. Non-steroidal Anti-inflammatory Drugs (NSAID) Raw Materials Suppliers in Global Market
Table 91. Typical Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream
Table 92. Non-steroidal Anti-inflammatory Drugs (NSAID) Downstream Clients in Global Market
Table 93. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type in 2022
Figure 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application in 2022
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, 2018-2030 (US$, Mn)
Figure 7. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2022
Figure 9. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
Figure 11. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
Figure 12. By Type - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
Figure 15. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
Figure 16. By Application - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
Figure 20. By Region - Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
Figure 21. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
Figure 22. By Country - North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
Figure 23. US Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
Figure 28. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 29. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
Figure 37. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 41. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
Figure 43. By Country - South America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
Figure 44. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share, 2018-2030
Figure 48. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$, Mn), 2018-2030
Figure 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Non-steroidal Anti-inflammatory Drugs (NSAID) by Region, 2022 VS 2030
Figure 54. Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Value Chain
Figure 55. Marketing Channels
